Stocks and Investing Stocks and Investing
Thu, August 10, 2023

Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $72 on, Aug 10th, 2023


Published on 2024-10-28 05:46:48 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $62 to $72 on, Aug 10th, 2023.

Vamil has made no other calls on ANIP in the last 4 months.



There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Vamil


  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $60 on, Friday, July 21st, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $60 on, Tuesday, May 9th, 2023
  • Elliot Wilbur of "Raymond James" Maintained at Buy with Increased Target to $49 on, Tuesday, May 9th, 2023

Contributing Sources